Basics Alto Neuroscience Inc. IPO Date: February 2, 2024 Sector: Healthcare Industry: Biotech Market Cap: $293.78M Activated in VL: True Average Daily Range Avg Daily Range: $0.33 | 4.22% Avg Daily Range (30 D): $0.44 | 7.60% Avg Daily Range (90 D): $0.22 | 4.80% Institutional Daily Volume Avg Daily Volume: .42M Avg Daily Volume (30 D): 2.4M Avg Daily Volume (90 D): .9M Trade Size Avg Trade Size (Sh.): 106 Avg Trade Size (Sh.) (30 D): 106 Avg Trade Size (Sh.) (90 D): 108 Institutional Trades Total Inst.Trades: 69 Avg Inst. Trade: $1.62M Avg Inst. Trade (30 D): $.57M Avg Inst. Trade (90 D): $1.22M Avg Inst. Trade Volume: .17M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.17M Avg Closing Trade (30 D): $3.88M Avg Closing Trade (90 D): $3.88M Avg Closing Volume: 323.58K     News Oct 7, 2025 @ 10:05 PM ALTO ALERT: Bragar Eagel & Squire, P.C. is Investi... Source: Bragar Eagel & Squire, P.C. Sep 19, 2025 @ 8:49 PM Investors who lost money on Alto Neuroscience, Inc... Source: Levi & Korsinsky, Llp Sep 19, 2025 @ 1:50 PM ANRO DEADLINE TODAY: ROSEN, A HIGHLY RECOGNIZED LA... Source: Rosen Law Firm Sep 18, 2025 @ 8:00 PM ANRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman Llc Sep 18, 2025 @ 3:40 AM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates ... Source: James (Josh) Wilson Financials   TTM Q1 2025 Q4 2024 Basic EPS $-2.34 $-.56 $-.56 Diluted EPS $-2.34 $-.56 $-.56 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -63.18M $ -15.17M $ -15.2M Operating Income / Loss $ -69.9M $ -15.68M $ -17M Cost of Revenue $ $ $ Net Cash Flow $ -44.64M $ -7.48M $ -13.47M PE Ratio